About Us
Leadership Team
Partnering
Presentations & Webcasts
Our Approach
Pipeline
Varoglutamstat
Expanded Access Policy
Investors & News
Stock Information
News&Events
Presentations & Webcasts
Financial Information
Corporate Governance
Shareholders´ Meetings
Email Alerts
Contact Us
Careers
✕
Probiodrug geht an die Amsterdamer Börse Euronext
Probiodrug announces its intention to launch an Initial Public Offering and listing on Euronext Amsterdam
Probiodrug launches its Initial Public Offering and listing on Euronext Amsterdam
Probiodrug announces its intention to launch an Initial Public Offering and listing on Euronext Amsterdam
Probiodrug launches its Initial Public Offering and listing on Euronext Amsterdam
Probiodrug geht an die Amsterdamer Börse Euronext
Related posts
Probiodrug to attend and present at International Conferences in February 2017
Read more
Probiodrug announces completion of recruitment for the SAPHIR Phase 2a study of Glutaminyl Cyclase Inhibitor PQ912 in early Alzheimer’s disease patients
Read more
Probiodrug to attend International Conferences in January 2017
Read more
